Alembic Pharma receives approval for gVibramycin capsules

Alembic Pharma's shares are up 7% today on the back of approval to gVibramycin capsules.

from India Infoline News Service https://ift.tt/2sWbWbu

Comments

Popular posts from this blog

CAG flags tax irregularities by banks, NBFCs

IIT PhDs in demand for high-end R&D jobs